Request Demo
Last update 22 Mar 2026
Shanghai Xinpu Biotechnology Co., Ltd.
Private Company|2016
Private Company|2016
Last update 22 Mar 2026
Overview
Basic Info
Introduction Based in Shanghai, Xinwan Biotechnology Co., Ltd. operates as an avant-garde biotech entity focused on the development of cutting-edge immunotherapeutic and immune assessment technologies. Embracing the core vision of enhancing human health and enriching the quality of life, this pioneering company is dedicated to sharing the advancements in immunology with people globally. Committed to innovation at its inception, Xinwan Biotechnology strives to deliver immune-based solutions that are more effective and accessible, aiming to address the growing clinical demands of cancer patients worldwide. |
Tags
Hemic and Lymphatic Diseases
Neoplasms
Immune System Diseases
Personalized antigen vaccine
mRNA vaccine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT07334574
A Safety, Tolerability and Efficacy Study of XP-006 Personalized Tumor mRNA Vaccine for Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
ChiCTR2500106571
A Phase I Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of XP-001-V2 in Patients with Advanced Solid Tumors
NCT06980155
Clinical Study of XP-005 Personalized Vaccine Alone or in Combination With Toripalimab to Prevent the Relapse of Acute Myeloid Leukemia After Consolidation Therapy
100 Clinical Results associated with Shanghai Xinpu Biotechnology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanghai Xinpu Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Xinpu Biotechnology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 11 Apr 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free